Impact of Platelet Reactivity on Long-term Clinical Outcomes and Bleeding Events in Japanese Patients Receiving Antiplatelet Therapy with Aspirin-Reference-Cited by-同舟云学术

Impact of Platelet Reactivity on Long-term Clinical Outcomes and Bleeding Events in Japanese Patients Receiving Antiplatelet Therapy with Aspirin

Published:2012 Issue:12 Volume:19 Page:1142-1153
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Yamane Keiichiro,Ikeda Tomoyuki,Taniguchi Ryoji,Watanabe Shin,Kawato Mitsunori,Kondo Hirokazu,Shirakawa Ryutaro,Higashi Tomohito,Toma Masanao,Tabuchi Arata,Tamura Toshihiro,Takahashi Kanako,Watanabe Haruyo,Yoshikawa Yuka,Kita Toru,Kimura Takeshi,Horiuchi Hisanori

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Reference38 articles.

1. 1) Horiuchi H: Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problems. Ann Med, 2006; 38: 162-172

2. 2) Antiplatelet Trialists’ Collaboration: Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002; 324: 71-86

3. 3) King SB, 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O’Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW: 2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation, 2008; 117: 261-295

4. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

5. Aspirin for Primary Prevention of Atherosclerotic Disease in Japan

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of Antithrombotic Therapy;Journal of Atherosclerosis and Thrombosis;2020-03-01

2. The prognostic utility of tests of platelet function for the detection of ‘aspirin resistance’ in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation;Health Technology Assessment;2015-05

3. A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study;BMJ Open;2015-01-09

4. SOYA ISOFLAVONES AND EVIDENCES ON CARDIOVASCULAR PROTECTION;NUTR HOSP;2014

5. A Short-Term Effect of Low-Dose Aspirin on Major Hemorrhagic Risks in Primary Prevention: A Case-Crossover Design;PLoS ONE;2014-05-30